CEO & Founder

Chief Technology Officer

Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors

Enveda raises another $150M, claims unicorn status

Enveda Raises $150M Series D Funding to Reach Unicorn Sta...

Enveda Biosciences Completes $150M Series D

Sr. Director, Clinical Development

Enveda is a company focused on transforming natural compounds into life-changing medicines. As a Sr. Director of Clinical Development, you will lead clinical development activities, design clinical studies, and prepare regulatory documents to accelerate the mission of bringing drugs from the bench to the clinic.

Sign up with Google

Sign in with Google